SE9503620L - Användning av proteinet S-100b för framställning av läkemedel för nervceller - Google Patents
Användning av proteinet S-100b för framställning av läkemedel för nervcellerInfo
- Publication number
- SE9503620L SE9503620L SE9503620A SE9503620A SE9503620L SE 9503620 L SE9503620 L SE 9503620L SE 9503620 A SE9503620 A SE 9503620A SE 9503620 A SE9503620 A SE 9503620A SE 9503620 L SE9503620 L SE 9503620L
- Authority
- SE
- Sweden
- Prior art keywords
- protein
- pct
- drugs
- manufacture
- nerve cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9503620A SE505316C2 (sv) | 1995-10-17 | 1995-10-17 | Användning av proteinet S-100b för framställning av läkemedel för nervceller |
CZ981166A CZ116698A3 (cs) | 1995-10-17 | 1996-10-15 | Použití proteinu S-100 v medicíně a léčivo obsahující protein S100-b |
EE9800108A EE9800108A (et) | 1995-10-17 | 1996-10-15 | Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid |
EP96935706A EP0952844A1 (en) | 1995-10-17 | 1996-10-15 | USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
NZ320721A NZ320721A (en) | 1995-10-17 | 1996-10-15 | Use of the S-100b protein as a medicine to treat amyotrophic lateral sclerosis or multiple sclerosis |
CA002235278A CA2235278A1 (en) | 1995-10-17 | 1996-10-15 | Use of protein s-100b in medicines and medicines containing the protein s-100b |
AU73523/96A AU713332B2 (en) | 1995-10-17 | 1996-10-15 | Use of protein S-100b in medicines and medicines containing the protein S-100-b |
US09/051,589 US5990080A (en) | 1995-10-17 | 1996-10-15 | Use of protein S-100-b in medicines containing the protein S-100b |
PCT/SE1996/001305 WO1997014427A1 (en) | 1995-10-17 | 1996-10-15 | USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
JP9515742A JPH11515003A (ja) | 1995-10-17 | 1996-10-15 | タンパク質S−100bの薬剤への使用法、および該タンパク質S−100bを含む薬剤 |
NO981719A NO981719L (no) | 1995-10-17 | 1998-04-16 | Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9503620A SE505316C2 (sv) | 1995-10-17 | 1995-10-17 | Användning av proteinet S-100b för framställning av läkemedel för nervceller |
Publications (4)
Publication Number | Publication Date |
---|---|
SE9503620D0 SE9503620D0 (sv) | 1995-10-17 |
SE9503620L true SE9503620L (sv) | 1997-04-18 |
SE505316C3 SE505316C3 (sv) | 1997-04-18 |
SE505316C2 SE505316C2 (sv) | 1997-08-04 |
Family
ID=20399846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9503620A SE505316C2 (sv) | 1995-10-17 | 1995-10-17 | Användning av proteinet S-100b för framställning av läkemedel för nervceller |
Country Status (11)
Country | Link |
---|---|
US (1) | US5990080A (sv) |
EP (1) | EP0952844A1 (sv) |
JP (1) | JPH11515003A (sv) |
AU (1) | AU713332B2 (sv) |
CA (1) | CA2235278A1 (sv) |
CZ (1) | CZ116698A3 (sv) |
EE (1) | EE9800108A (sv) |
NO (1) | NO981719L (sv) |
NZ (1) | NZ320721A (sv) |
SE (1) | SE505316C2 (sv) |
WO (1) | WO1997014427A1 (sv) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258776B1 (en) * | 1997-08-12 | 2001-07-10 | Novartis Ag | Calcium-regulated kinase |
US20020072493A1 (en) | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
US20030108528A1 (en) * | 1998-05-19 | 2003-06-12 | Michal Eisenbach-Schwartz | Activated t-cells, nervous system-specific antigens and their uses |
EP1080110A2 (en) * | 1998-05-19 | 2001-03-07 | Yeda Research And Development Co. Ltd. | Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
DE19915485A1 (de) | 1999-04-07 | 2000-10-19 | Hugo A Katus | Therapie der Herzinsuffizienz |
DK1429800T3 (da) | 2001-12-06 | 2009-04-27 | Yeda Res & Dev | Vaccine og anvendelse deraf til behandling af amyotrofisk lateral sklerose |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9164591A (en) * | 1990-12-14 | 1992-07-08 | New York University | Functional interactions between glial s-100b and central nervous system serotonergic neurons |
-
1995
- 1995-10-17 SE SE9503620A patent/SE505316C2/sv not_active IP Right Cessation
-
1996
- 1996-10-15 CA CA002235278A patent/CA2235278A1/en not_active Abandoned
- 1996-10-15 EP EP96935706A patent/EP0952844A1/en not_active Ceased
- 1996-10-15 NZ NZ320721A patent/NZ320721A/en unknown
- 1996-10-15 CZ CZ981166A patent/CZ116698A3/cs unknown
- 1996-10-15 JP JP9515742A patent/JPH11515003A/ja not_active Withdrawn
- 1996-10-15 US US09/051,589 patent/US5990080A/en not_active Expired - Fee Related
- 1996-10-15 EE EE9800108A patent/EE9800108A/xx unknown
- 1996-10-15 AU AU73523/96A patent/AU713332B2/en not_active Ceased
- 1996-10-15 WO PCT/SE1996/001305 patent/WO1997014427A1/en not_active Application Discontinuation
-
1998
- 1998-04-16 NO NO981719A patent/NO981719L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO981719L (no) | 1998-06-16 |
SE505316C2 (sv) | 1997-08-04 |
CA2235278A1 (en) | 1997-04-24 |
EE9800108A (et) | 1998-10-15 |
NO981719D0 (no) | 1998-04-16 |
CZ116698A3 (cs) | 1998-09-16 |
JPH11515003A (ja) | 1999-12-21 |
SE9503620D0 (sv) | 1995-10-17 |
AU713332B2 (en) | 1999-12-02 |
US5990080A (en) | 1999-11-23 |
NZ320721A (en) | 2000-07-28 |
EP0952844A1 (en) | 1999-11-03 |
WO1997014427A1 (en) | 1997-04-24 |
AU7352396A (en) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1369297A (en) | Medical implant | |
DE59009462D1 (de) | Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper. | |
ES2184895T3 (es) | Sistema no polimerico de administracion con liberacion retardada. | |
DE69530919D1 (de) | Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung | |
PT1061940E (pt) | Utilizacao de foliestatina para a producao de um medicamento para o tratamento de disturbios relacionados com os musculos | |
UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
TW326394B (en) | Insulin formulation | |
DE69113470D1 (de) | Intraokulares und intraorbitales Implantat zur kontrollierten Zuführung von Arzneimitteln. | |
FI952701A0 (sv) | Process för behandling av en metallisk kirurgisk implantat | |
ZA944347B (en) | The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation | |
NO962088L (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
DE69922143D1 (de) | Implantierbares system mit medikamentenabgebenden zellen zur lokalen verabreichung von medikamenten bei bedarf | |
DE122007000002I2 (de) | Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes. | |
NO953278D0 (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
ATE141792T1 (de) | Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson- syndromen | |
SE9503620L (sv) | Användning av proteinet S-100b för framställning av läkemedel för nervceller | |
UA26845C2 (uk) | Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а | |
GR3023962T3 (en) | Drugs containing diphosphonic acids and salts thereof. | |
ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
HUP9901303A2 (hu) | Gyógyszerkészítmény autoimmun betegségek kezelésére | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
MX9803610A (es) | Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico. | |
AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
RU98109592A (ru) | Применение белка s-100b в лекарственных средствах и лекарственные средства, содержащие белок s-100b | |
UA5743C2 (uk) | Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 9503620-8 Format of ref document f/p: F |